中国临床药理学与治疗学2011，Vol.16Issue(12)：1410-1413,4.
参麦注射液对肿瘤化疗患者血常规和CD4/CD8比例的影响
Effection of Shenmai Injection for chemotherapy patients with cancer on blood tests and CD4/CD8 ratio
周月芬 1吴敏华 1陈旭烽 1应筱莉 1谢艳茹 1王永辉 1楼建1
作者信息
- 1. 温州医学院附属第五医院丽水市中心医院肿瘤内科,丽水323000,浙江
- 折叠
摘要
Abstract
AIM: To study the effect of Shen-mai Injection for gastrointestinal tumor patients after operation with oxaliplatin chemotherapy on blood tests and CD4/CD8 level. METHODS: Eighty cases of gastrointestinal tumor patients' after operation with oxaliplatin chemotherapy were divided into single group and combined group, each 40 cases. The single group was administered by chemotherapy only while the combined group by chemotherapy and Shenmai Injection. After 6 cycle chemotherapy, TCM symptoms integral, neutrophils, CD4/CD8 ratio were compared between two groups. RESULTS; Compared with the single group, the TCM symptoms integral of the combined group wasless (P< 0. 01). Compared with the single group, the neutrophils level of the combined group was less (P<0. 05). Compared with the single group, the CD4 level and CD4/CD8 ratio were more and statistically significant (P < 0.05). CONCLUSION; Shenmai Injection can improve chemotherapy related symptoms and reduce bone marrow toxicity; it can also adjust chemotherapy patient's immune status and ensure chemotherapy smoothly.关键词
参麦注射液/肿瘤/血常规/CD4/CD8Key words
Shenmai Injection/Tumor/Blood routine/CD4/CD8分类
医药卫生引用本文复制引用
周月芬,吴敏华,陈旭烽,应筱莉,谢艳茹,王永辉,楼建..参麦注射液对肿瘤化疗患者血常规和CD4/CD8比例的影响[J].中国临床药理学与治疗学,2011,16(12):1410-1413,4.
